Stockscreener 앱 받기
1.67
2.34%
-0.04
시장 영업 전:
1.67
Compugen Ltd 주식(CGEN)의 최신 뉴스
Compugen announces the appointment of Michele Holcomb, Ph.D., to its board of directors - marketscreener.com
Compugen Adds Veteran Healthcare Strategist Michele Holcomb to Board of Directors - TipRanks
Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors - Yahoo Finance
Aug Mood: Whats the analyst consensus on Compugen LtdMarket Growth Report & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Earnings Miss: Will Prime Medicine Inc stock hit new highs in YEARJuly 2025 Spike Watch & AI Driven Price Forecasts - baoquankhu1.vn
Compugen (NASDAQ:CGEN) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Quarterly Recap: Should I invest in Star Bulk Carriers Corp. before earnings2025 Earnings Surprises & Daily Stock Momentum Reports - baoquankhu1.vn
Compugen secures $90 million in a strategic royalty monetization deal with AstraZeneca - MSN
Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Compugen (NASDAQ:CGEN) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Can Compugen Ltd. maintain sales growthHead and Shoulders Patterns & Small Budget Wealth Tips - Bollywood Helpline
Aug Opening: Can Fidelis Insurance Holdings Limited stock outperform in a bear marketRate Hike & Stepwise Trade Execution Plans - baoquankhu1.vn
Compugen (NASDAQ:CGEN) Stock Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Can Compugen Ltd maintain sales growthEarnings Growth Summary & Stock Portfolio Risk Management - baoquankhu1.vn
Update Recap: Can Compugen Ltd stock continue upward trendPortfolio Value Report & Smart Money Movement Alerts - Bộ Nội Vụ
Targets Report: Will Compugen Ltd stock outperform tech sector in 2025July 2025 Volume & High Win Rate Trade Tips - Bộ Nội Vụ
Compugen shares jump after $65 million royalty monetization deal with AstraZeneca - MSN
Why Compugen Ltd. stock could benefit from AI revolutionRate Cut & Intraday High Probability Alerts - Улправда
Brokers Issue Forecasts for Compugen FY2025 Earnings - Defense World
HC Wainwright Estimates Compugen FY2025 Earnings - MarketBeat
Compugen (NASDAQ:CGEN) Coverage Initiated at HC Wainwright - Defense World
Compugen rises on royalty deal with AstraZeneca - MSN
Comparing Compugen (NASDAQ:CGEN) & Psyence Biomedical (NASDAQ:PBM) - Defense World
How buybacks impact Compugen Ltd. stock valueRate Hike & Capital Efficiency Focused Strategies - Улправда
Why Compugen Ltd. stock could rally in 2025Quarterly Portfolio Review & AI Optimized Trading Strategy Guides - Улправда
Will Compugen Ltd. stock benefit from infrastructure spending2025 Dividend Review & Low Volatility Stock Suggestions - Улправда
Compugen (NASDAQ:CGEN) Stock Rating Upgraded by HC Wainwright - MarketBeat
Is Compugen Ltd. stock a bargain at current levelsMoving Average Strategies & Expert-Backed Recommendations That Deliver - Улправда
H.C. Wainwright initiates coverage on Compugen stock with Buy rating By Investing.com - Investing.com Nigeria
Compugen (CGEN): HC Wainwright Initiates Coverage with 'Buy' Rat - GuruFocus
H.C. Wainwright initiates coverage on Compugen stock with Buy rating - Investing.com
This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
HC Wainwright & Co. Initiates Coverage of Compugen (CGEN) with Buy Recommendation - Nasdaq
Operating cash flow per share of Compugen Ltd. – TASE:CGEN - TradingView — Track All Markets
Will Compugen Ltd. stock benefit from sector rotationWeekly Profit Summary & Daily Growth Stock Tips - Улправда
Is Compugen Ltd. stock a defensive play in 2025Portfolio Gains Summary & Real-Time Volume Analysis Alerts - Улправда
Can Compugen Ltd. stock deliver strong Q4 earningsJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - Улправда
Compugen stock soars on $65 million AstraZeneca royalty deal By Investing.com - Investing.com Australia
Compugen Secures $90 Million in a Strategic Royalty Monetization Deal with AstraZeneca - TipRanks
Compugen (CGEN) Rises on Royalty Deal with AstraZeneca - GuruFocus
Compugen restructures AstraZeneca deal to boost cash coffers - גלובס
Compugen stock soars on $65 million AstraZeneca royalty deal - Investing.com
Compugen Monetizes Portion of Cancer Treatment Future Royalties to AstraZeneca for Up to $90 Million - marketscreener.com
Compugen rises on royalty deal with AstraZeneca (CGEN:NASDAQ) - Seeking Alpha
1.24%
0.19%
자본화:
|
볼륨(24시간):